| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.2K | $174.14M | - | |
| VP | 83.4K | $28.74M | - | |
| VP | 51.2K | $17.66M | - | |
| CFO | 50.7K | $17.48M | - | |
| VP | 42.8K | $14.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2017 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $185.95 | $283,573.75 | -2.5% | |
| May 31, 2017 | Baltimore David | Director | Sell | 3,700 | $153.93 | $569,541.00 | -10.6% | |
| May 24, 2017 | Patton Cynthia M | SVP &CCO | Sell | 2,922 | $154.40 | $451,164.11 | -12.1% | |
| Aug 2, 2016 | Such Annette Louise | VP, Finance And CAO | Sell | 3,000 | $174.59 | $523,758.00 | -29.5% | |
| May 4, 2016 | Balachandran Madhavan52 | EVP, Operations | Sell | 30,000 | $154.12 | $4,623,624.00 | -34.9% | |
| Apr 29, 2016 | Baltimore David | Director | Sell | 3,312 | $157.21 | $520,683.83 | -9.3% | |
| Apr 29, 2016 | Harper Sean E | EVP, Research &Development | Sell | 21,875 | $157.99 | $3,456,134.06 | -34.1% | |
| Mar 2, 2016 | Bradway Robert A | Chairman, CEO And President | Sale+OE | 20,000 | $146.48 | $2,929,566.00 | -5.0% | |
| Aug 31, 2015 | De Carbonnel Francois | Director | Sell | 5,000 | $153.84 | $769,192.00 | -24.8% | |
| Aug 19, 2015 | Hassan Fred | Director | Buy | 3,010 | $166.63 | $501,562.10 | +72.6% |